CClinicalTrials.gg
CompletedNCT05463302Updated Apr 3, 2025

Investigating the Efficacy of Sleepgift Blanket on Sleep Quality and Heart Health

An Early Phase 1 interventional study of Active sleepgift blanket and Sham Sleepgift Blanket in Sleep, sponsored by University of Manitoba. Completed at 1 site in Canada. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-03.

Sponsored by University of Manitoba · Early Phase 1, Interventional, and Treatment

Phase
Early Phase 1
Study type
Interventional
Enrollment
31
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Exposure to electromagnetic field (EMF) emitted by mobile phones and devices with WIFI is on the rise and so is the EMF effects on sleep quality and well-being of individuals with high exposures to EMF. Some studies have shown poor sleep quality among individuals with long-term occupational exposure to EMF, and some have shown association between EMF long-term exposure and neuropsychiatric disorders including depression. This study aims to investigate a commercially available EMF- blocker blanket, called Sleepgift, that claims helping people to have a better sleep and improved health. We will investigate the Sleepgift efficacy on adults' quality of sleep and their vital signals as a measure of their well-being in a placebo-controlled single- blind cross-over designed study. Participants will sleep in our sleep lab at baseline and then 10 days later with the Sleepgift blanket after using it every night for the past 10 consecutive days. Participants will be given two blankets for each cycle of the study as it is a cross-over designed study: one Sleepgift and one regular blanket; they will not know which one is real or sham. There will be one-month washout period between the two cycles of the cross-over study. We aim to enroll 30 adults for the study. Participants' sleep quality will be measured by the established device called Prodogy; their vital signals will also be measured and monitored through the night. The collected data will be analyzed statistically for any significant effect of the Sleepgift blanket on sleep quality and vital signals such as heart's rhythm and heart rate variability.

02

Conditions studied

  • Sleep

Keywords

  • electromagnetic field effect
  • sleep quality
  • EMF blocker
03

In context

Lead sponsor

University of Manitoba is the lead sponsor of 542 studies on the registry; 87 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 5 (42%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18 y\<age\<70 years
  • Being generally healthy (cognitively and psychologically)
  • ability to read, write and speak English fluently.

Exclusion criteria

Exclusion Criteria:

  • Being diagnosed with any neurological, intellectual disability, major depression/anxiety, bipolar disorder, schizophrenia or any other major mood disorder.
  • Inability to adequately communicate in English
  • Current substance abuse disorder
  • Currently participating in another therapeutic study
  • Being on a regular pain killer, sleeping or depression pill.
05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
31 participants (actual)

Study arms

  • Active comparator
    Active EMF blanket

    participants will receive the real EMF blocker blanket

    Device: Active sleepgift blanket · Device: Sham Sleepgift Blanket

  • Placebo comparator
    Sham EMF blanket

    participants will receive the sham EMF blocker blanket

    Device: Active sleepgift blanket · Device: Sham Sleepgift Blanket

Interventions

  • DeviceActive sleepgift blanket

    Participants for group1 will be provided with real/active sleepgift blanket first for 10 consecutive nights and then cross over.

  • DeviceSham Sleepgift Blanket

    Participants for group 2 will be provided with sham sleepgift blanket for 10 consecutive nights and then cross over.

06

What researchers measure

Primary outcomes

  1. Sleep quality measure

    The change in the value of Odds of the Product (ORP) from baseline line to post-intervention, measured by the Prodigy device which is a combination of the EEG band waves. ORP is only one value output of the device.

    Time frame: Through study completion, 2 years approximately

Secondary outcomes

  1. heart rate variability

    the change in heart rate variability (HRV) measured from beat to beat R-R interval.

    Time frame: Through study completion, 2 years approximately

07

Study locations

1 site
  • Riverview Health Center
    Winnipeg, Manitoba R3L 2P4, Canada
08

References and documents

Individual participant data

Plan to share: Yes — When the study is finished, de-identified data could be shared publicly by other researchers.

Supporting information: Study protocol, Sap, Icf

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05463302
Lead sponsor
University of Manitoba
Collaborators
BB Holistics
Responsible party
Sponsor
First posted
Jul 18, 2022
Start date
Jan 1, 2023
Primary completion
Oct 11, 2024
Completion
Oct 11, 2024
Last update
Apr 3, 2025

Study contacts

Zahra Moussavi, Ph.D.
principal investigator · University of Manitoba

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion